Rocket Lab SEC Filings

Arjun Kampani, SVP General Counsel of Rocket Lab USA, sold 10,554 shares on 11/26/2025 at weighted average prices of $41.96 and $43.16. The sales were automatic under a Rule 10b5-1 trading plan adopted on December 12, 2024. This is a neutral signal as it is a pre-scheduled disposition not reflecting current market views.

Frank Klein, Chief Operations Officer of Rocket Lab USA Inc., sold 4,736 shares of common stock on 11/26/2025 at weighted average prices of $41.96 and $43.16. The sales were executed automatically under a Rule 10b5-1 trading plan adopted on December 13, 2024. This is a neutral signal as it is a pre-scheduled, non-discretionary transaction.

Peter Beck, CEO and Director of Rocket Lab USA Inc., acquired 132,426 restricted stock units (RSUs) on November 15, 2025, at $0.00 per share. On November 24, 2025, he sold 18,857 shares in three sell-to-cover transactions totaling approximately $767K to satisfy tax withholding on vesting RSUs. This is a neutral signal, as the sales are routine and non-discretionary.

Arjun Kampani, SVP General Counsel, executed sell-to-cover transactions totaling 28,615 common shares on 11/24/2025 to satisfy tax withholding on vesting RSUs. His direct holdings decreased to 461,014 shares. This is a neutral signal, as it is non-discretionary and routine.

Frank Klein, Chief Operations Officer, executed sell-to-cover sales of 41,782 common shares on 11/24/2025 to cover tax withholding from RSU vesting. Transactions at weighted avg prices $40.02-$41.35, post-sale direct holdings 1,274,223 shares. Neutral signal as routine non-discretionary.

Chief Financial Officer Adam C. Spice sold a total of 62,627 common shares across three transactions on Nov 22 and 24, 2025. These were sell-to-cover transactions to satisfy tax obligations from vesting restricted stock units. The signal is neutral as it represents routine compensation-related activity rather than discretionary selling.

Rocket Lab officer Peter Beck filed Form 144 on 11/24/2025 notifying proposed sale of 18,857 common shares (market value ~$766k) via broker Morgan Stanley. Shares stem from vesting of 47,744 RSUs on 11/22/2025, with sale covering tax obligations. Relevant to investors as routine insider transaction confirming no known material adverse information.

Rocket Lab officer Arjun Kampani filed Form 144 on 2025-11-24 notifying intent to sell 28,615 common shares (aggregate value ~$1.16M) on or around 11/24/2025. Shares stem from recent restricted stock vesting on 11/22/2025, with sale proceeds covering tax obligations. This routine insider transaction follows prior sales totaling ~40,601 shares in September 2025.

Form 144 discloses Rocket Lab Corp officer Frank Klein's intent to sell 41,782 common shares (market value $1.7M) on 11/24/2025. Shares stem from 81,250 RSUs vesting on 11/22/2025 as compensation, with sale covering tax obligations. Recent sales include 49,821 shares in September 2025 for $2.43M total.

Form 144 discloses COO Adam Spice's proposed sale of 62,627 common shares (market value $2.55M) on 11/24/2025, primarily to cover taxes from 114,845 RSUs vesting on 11/22/2025. Spice sold 942,842 shares for $45.3M in the past 3 months. Routine insider transaction with no undisclosed material adverse info.